solo para uso en investigación

NSC 74859 (S3I-201) STAT3 Inhibitor

Cat. No.: S1155

NSC 74859 (S3I-201) shows potent inhibition of STAT3 DNA-binding activity with IC50 of 86 μM in cell-free assays, and low activity towards STAT1 and STAT5.
NSC 74859 (S3I-201) STAT inhibitor Chemical Structure

Estructura química

Peso molecular: 365.36

Saltar a

Control de calidad (Quality Control)

Lote: Pureza: 99.28%
99.28

Cultivo celular, tratamiento y concentración de trabajo
(Cell Culture, Treatment & Working Concentration)

Líneas celulares Tipo de ensayo Concentración Tiempo de incubación Formulación Descripción de la actividad PMID
U87 Growth Inhibition Assay 72 h IC50=55.1 μM 20072652
U373  Growth Inhibition Assay 72 h IC50=52.5 μM 20072652
HPAC Growth Inhibition Assay 72 h IC50>100 μM 20072652
PANC-1 Growth Inhibition Assay 72 h IC50>100 μM 20072652
SK-BR-3 Growth Inhibition Assay 72 h IC50>100 μM 20072652
 U-373 MG Cytotoxicity Assay 3/10 μM 24 h reduces FN-γ-induced cell neurotoxicity 20888416
MDA-MB-231 Growth Inhibition Assay 72 h IC50>100 μM 20072652
HUVEC  Function Assay 0.5-20 μM 24 h DMSO suppresses the hypoxia-induced accumulation of HIF-1α 21523559
Huh7 Growth Inhibition Assay 100 nM 48 h DMSO inhibits the IL-6 stimulation promoted cell proliferation 23364389
PLC/PRF/5  Growth Inhibition Assay 100 nM 48 h DMSO inhibits the IL-6 stimulation promoted cell proliferation 23364389
H460  Function Assay 50/100 μM 48 h inhibits the Stat3C increased miR-92a expression 23820254
H1299 Function Assay 50/100 μM 48 h suppresses miR-92a expression dose-dependently 23820254
T-cell  Growth Inhibition Assay IC50=50 μM 24068731
U373  Growth Inhibition Assay 125 μM 24 h DMSO disrupts STAT3 signaling and proliferation 24070820
HUT-102 Apoptosis Assay 75-300 μM 24/48 h suppresses cell proliferation in a dose-dependent manner and induces cell apoptosis  24090995
MT-2 Apoptosis Assay 75-300 μM 24/48 h suppresses cell proliferation in a dose-dependent manner and induces cell apoptosis  24090995
H460  Apoptosis Assay 100 nM 24 h enhances cell death co-treated with LY294002 24472538
A459 Apoptosis Assay 100 nM 24 h induces cell apoptosis co-treated with BEZ235 24472538
H460  Apoptosis Assay 100 nM 24 h induces cell apoptosis co-treated with BEZ235 24472538
GC  Growth Inhibition Assay 50-125 μM 72 h attenuates the cell growth in a dose-dependent manner 25774503
GH3 Growth Inhibition Assay 50-125 μM 72 h attenuates the cell growth in a dose-dependent manner 25774503
BT474R  Function Assay 50 μM 10-60 d inhibits STAT3 activity 25327561
NCI-N87R Function Assay 50 μM 10-60 d inhibits STAT3 activity 25327561
MDA-MB-468 Function assay 100 uM 24 hrs Inhibition of Stat3 activation in human MDA-MB-468 cells at 100 uM after 24 hrs 17463090
MDA-MB-435 Function assay 100 uM 24 hrs Inhibition of Stat3 activation in human MDA-MB-435 cells at 100 uM after 24 hrs 17463090
MDA-MB-231 Function assay 100 uM 24 hrs Inhibition of Stat3 activation in human MDA-MB-231 cells at 100 uM after 24 hrs 17463090
NIH3T3 Function assay 100 uM 24 hrs Reduction of pTyr-705 Stat3 level in v-Src expressing mouse NIH3T3 cells at 100 uM after 24 hrs 17463090
NIH3T3 Growth inhibition assay 100 uM 4 days Growth inhibition of mouse NIH3T3 cells expressing v-Src at 100 uM after 4 days by trypan blue exclusion assay 17463090
MDA-MB-435 Growth inhibition assay 100 uM 4 days Growth inhibition of human MDA-MB-435 cells expressing v-Src at 100 uM after 4 days by trypan blue exclusion assay 17463090
MDA-MB-231 Growth inhibition assay 100 uM 4 days Growth inhibition of human MDA-MB-231 cells expressing v-Src at 100 uM after 4 days by trypan blue exclusion assay 17463090
MDA-MB-468 Growth inhibition assay 100 uM 4 days Growth inhibition of human MDA-MB-468 cells expressing v-Src at 100 uM after 4 days by trypan blue exclusion assay 17463090
NIH3T3 Growth inhibition assay 100 uM Growth inhibition of mouse NIH3T3 cells expressing v-Ras at 100 uM for every 3 days by soft-agar colony-formation assay 17463090
MDA-MB-435 Apoptosis assay 30 to 100 uM 48 hrs Induction of apoptosis in human MDA-MB-435 cells expressing active Stat3 at 30 to 100 uM after 48 hrs 17463090
MDA-MB-231 Apoptosis assay 100 uM 24 hrs Reduction of apoptosis in Stat3 transfected human MDA-MB-231 cells at 100 uM after 24 hrs 17463090
MDA-MB-231 Function assay 100 uM 48 hrs Reduction of cyclin D1 gene expression in human MDA-MB-231 cells at 100 uM after 48 hrs 17463090
MDA-MB-231 Apoptosis assay 100 uM 24 hrs Induction of apoptosis in Stat3 SH2 domain transfected human MDA-MB-231 cells at 100 uM after 24 hrs 17463090
MDA-MB-231 Apoptosis assay 100 uM 24 hrs Induction of apoptosis in Stat3C transfected human MDA-MB-231 cells at 100 uM after 24 hrs 17463090
NIH3T3 Function assay 100 uM 48 hrs Reduction of cyclin D1 gene expression in v-Src transfected mouse NIH3T3 cells at 100 uM after 48 hrs 17463090
NIH3T3 Function assay 100 uM 48 hrs Reduction of Bcl-xL gene expression in v-Src transfected mouse NIH3T3 cells at 100 uM after 48 hrs 17463090
NIH3T3 Function assay 100 uM 48 hrs Reduction of survivin gene expression in v-Src transfected mouse NIH3T3 cells at 100 uM after 48 hrs 17463090
MDA-MB-231 Function assay 100 uM 48 hrs Reduction of Bcl-xL gene expression in human MDA-MB-231 cells at 100 uM after 48 hrs 17463090
MDA-MB-231 Function assay 100 uM 48 hrs Reduction of survivin gene expression in human MDA-MB-231 cells at 100 uM after 48 hrs 17463090
MDA-MB-231 Antitumor assay 5 mg/kg 2 weeks Antitumor activity against human MDA-MB-231 cells expressing active Stat3 xenografted in mouse at 5 mg/kg, iv for every 3 days for 2 weeks 17463090
NIH3T3 Growth inhibition assay 100 uM Growth inhibition of mouse NIH3T3 cells expressing v-Src at 100 uM for every 3 days by soft-agar colony-formation assay 17463090
A673 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells 29435139
SK-N-MC qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells 29435139
NB1643 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells 29435139
LAN-5 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells 29435139
Haga clic para ver más datos experimentales de líneas celulares

Información química, almacenamiento y estabilidad (Chemical Information, Storage & Stability)

Peso molecular 365.36 Fórmula

C16H15NO7S

Almacenamiento (Desde la fecha de recepción)
Nº CAS 501919-59-1 Descargar SDF Almacenamiento de soluciones madre

Solubilidad (Solubility)

In vitro
Lote:

DMSO : 73 mg/mL (199.8 mM)
(El DMSO contaminado con humedad puede reducir la solubilidad. Usar DMSO fresco y anhidro.)

Water : Insoluble

Ethanol : Insoluble

Calculadora de Molaridad

Masa Concentración Volumen Peso molecular
Calculadora de Dilución Calculadora de Peso Molecular

In vivo
Lote:

Calculadora de formulación in vivo (Solución clara)

Paso 1: Introduzca la información a continuación (Recomendado: Un animal adicional para tener en cuenta la pérdida durante el experimento)

mg/kg g μL

Paso 2: Introduzca la formulación in vivo (Esto es solo la calculadora, no la formulación. Por favor, contáctenos primero si no hay una formulación in vivo en la sección de Solubilidad.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Resultados del cálculo:

Concentración de trabajo: mg/ml;

Método para preparar el líquido maestro de DMSO: mg fármaco predissuelto en μL DMSO ( Concentración del líquido maestro mg/mL, Por favor, contáctenos primero si la concentración excede la solubilidad del DMSO del lote del fármaco. )

Método para preparar la formulación in vivo: Tomar μL DMSO líquido maestro, luego añadirμL PEG300, mezclar y clarificar, luego añadirμL Tween 80, mezclar y clarificar, luego añadir μL ddH2O, mezclar y clarificar.

Método para preparar la formulación in vivo: Tomar μL DMSO líquido maestro, luego añadir μL Aceite de maíz, mezclar y clarificar.

Nota: 1. Por favor, asegúrese de que el líquido esté claro antes de añadir el siguiente disolvente.
2. Asegúrese de añadir el (los) disolvente(s) en orden. Debe asegurarse de que la solución obtenida, en la adición anterior, sea una solución clara antes de proceder a añadir el siguiente disolvente. Se pueden utilizar métodos físicos como el vórtice, el ultrasonido o el baño de agua caliente para ayudar a la disolución.

Mecanismo de acción (Mechanism of Action)

Características
A chemical probe inhibitor of Stat3 activity.
Targets/IC50/Ki
STAT3
(Cell-free assay)
86 μM
In vitro

NSC 74859 (S3I-201) inhibits growth and induces apoptosis preferentially in tumor cells that contain persistently activated Stat3 by inhibiting Stat3·Stat3 complex formation and Stat3 DNA-binding and transcriptional activities. Moreover, it also inhibits the expression of the Stat3-regulated genes encoding cyclin D1, Bcl-xL, and survivin.This compound inhibits breast carcinoma MDA-MB-435, MDA-MB-453 and MDA-MB-231 cell lines with IC50 of 100 μM. In addition, the cells with impaired TGF-β signaling are four times as sensitive to S3I-201.A recent study shows that it potentiates the antiproliferative effect in HepG2 and Huh-7 cells via the STAT3 signalling pathway.

Ensayo de quinasa
Ensayo de unión de STAT3 al ADN in vitro y análisis EMSA
Brevemente, se añaden 100 µL de biotinil-e-Ac-EPQpYEEIEL-OH (en 50 mM Tris/150 mM NaCl, pH 7,5) a cada pocillo de placas de microtitulación de 96 pocillos recubiertas de estreptavidina y se incuban con agitación a 4 °C durante la noche. Luego, las placas se enjuagan con PBS/Tween 20 y luego dos veces con 200 µL de BSA-T-PBS (0,2 % BSA/0,1 % Tween 20/PBS). Luego se añaden 50 µL de proteína de fusión Lck-SH2-GST (6,4 ng/ml en BSA-T-PBS) a cada pocillo de la placa de 96 pocillos en presencia y ausencia de 50 µL de NSC 74859 (S3I-201) (para concentraciones finales de 30 y 100 mM), y la placa se agita a temperatura ambiente durante 4 horas. Después de retirar las soluciones, cada pocillo se enjuaga cuatro veces con BSA-T-PBS (200 µL), y se añaden 100 µL de anticuerpo policlonal de conejo anti-GST (100 ng/mL en BSA-T-PBS) a cada pocillo y se incuba a 4 °C durante la noche. Después de lavar con BSA-T-PBS, se añaden 100 µL de anticuerpo de ratón anti-conejo conjugado con peroxidasa de rábano picante (200 ng/mL en BSA-T-PBS) a cada pocillo y se incuban durante 45 minutos a temperatura ambiente. Después de cuatro pasos de lavado con BSA-T-PBS y tres pasos de lavado con PBS-T, se añaden 100 µL de sustrato de peroxidasa a cada pocillo y se incuban durante 5-15 minutos. La reacción de peroxidasa se detiene añadiendo 100 µL de solución de ácido sulfúrico 1 M, y la absorbancia se lee a 450 nm con un lector de placas ELISA.
In vivo

NSC 74859 (S3I-201) (5 mg/kg, i.v. every 2 or every 3 days) shows the antitumor efficacy in mouse models with human breast tumor xenografts that harbor constitutively active Stat3.This compound treatment reduces Varicella-zoster virus (VZV) replication on the basis of the bioluminescence signal and the number of positive skin xenografts compared with DMSO-treated mice by inhibiting STAT3 phosphorylation.

Referencias
  • [4] https://pubmed.ncbi.nlm.nih.gov/22190485/

Aplicaciones (Applications)

Métodos Biomarcadores Imágenes PMID
Western blot STAT3 / p-STAT3 / Cyclin D1 / Bcl-2 / Nanog / OCT4 / ALDH1 / CD44 PD-L1
S1155-WB1
26556875
Immunofluorescence p-STAT3 Oct4 / Twist
S1155-IF1
26556875
Growth inhibition assay Cell viability
S1155-viability1
26813676